a novel intravenous therapy consisting of polyvalent igg antibodies to lipopolysaccharide ( lps , endotoxin ) obtained from screening of blood donors was used for treatment of patients with profound septic endotoxin shock .
C0023810
lps
C0014264
endotoxin